Call for head-to-head research for non-commercial clinical trials or research experiments ABM/2022/3
The Medical Research Agency plans to announce on July 11, 2022 the Call for Head-to-Head Research for Non-Commercial Clinical Trials or Research Experiments (ABM/2022/3)
Scientific advances in recent years have been associated with the emergence on the market of many different medical technologies that can be used to treat the same disease entity, which, on the one hand, expands the therapeutic options for many diseases - but on the other hand, poses a difficult task for policy makers and clinicians to evaluate and select the most effective therapy for a given indication.
According to the principles of Evidence-Based Medicine (EBM), the choice of therapy used in clinical practice should be based on reliable, high-quality clinical data, derived first from studies that allow direct comparison of the efficacy and safety of alternative therapeutic options, i.e. head-to-head studies.
ABM's support of head-to-head studies will improve the situation for patients, primarily by increasing knowledge regarding the most clinically optimal therapy, and by increasing access to new and effective treatment options.
Purpose and focus of the call
The main objective of the Call is to develop new standards for treatment, diagnosis, rehabilitation or prevention as part of ongoing non-commercial clinical trials or research experiments, as well as to increase knowledge of the most clinically optimal and cost-effective therapies.
Projects submitted under the Call must have the status of:
non-commercial clinical trials, concerning the evaluation of the effects of a medicinal product, or
research experiments.
Who can apply for funding ?
The call is addressed to entities such as: universities; federations of entities of the system of higher education and science; the Polish Academy of Sciences; scientific institutes of the Polish Academy of Sciences; research institutes; international scientific institutes; the Center for Medical Postgraduate Education; medical entities for which the forming subject is a public medical university or a university conducting teaching and research activities in medical sciences or the Center for Medical Postgraduate Education; Entrepreneurs with the status of a research and development center; entities conducting scientific research and development work that undertake the possibility of implementing projects in the form of non-commercial clinical trials or research experiments.
Planned deadline for submission of applications
July 11, 2022. - October 20, 2022.
How to submit applications
Applications will be submitted using the ABM ICT system, completing the application form in Polish or English.
Allocation earmarked for the call
PLN 100 million